{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:37:21Z","timestamp":1790671041957,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.jaci.2010.03.028","type":"journal-article","created":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T08:32:00Z","timestamp":1275381120000},"page":"1336-1343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":252,"title":["Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome"],"prefix":"10.1016","volume":"125","author":[{"given":"Sophia","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautham","family":"Marigowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Oren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Israel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Wechsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2010.03.028_bib1","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/pds.1353","article-title":"Asthma drug use and the development of Churg-Strauss syndrome (CSS)","volume":"16","author":"Harrold","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaci.2010.03.028_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/(SICI)1099-1557(199905\/06)8:3<179::AID-PDS414>3.0.CO;2-K","article-title":"Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies","volume":"8","author":"Martin","year":"1999","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaci.2010.03.028_bib3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/thx.54.9.771","article-title":"Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome","volume":"54","author":"Schnabel","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2010.03.028_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1196\/annals.1361.053","article-title":"Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome","volume":"1051","author":"Hellmich","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaci.2010.03.028_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaci.2009.10.014","article-title":"Sustained response to mepolizumab in refractory Churg-Strauss Syndrome","volume":"125","author":"Kahn","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.03.028_bib6","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jaci.2008.02.033","article-title":"Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels","volume":"121","author":"Stein","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.03.028_bib7","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jaci.2006.09.007","article-title":"Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis","volume":"118","author":"Stein","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.03.028_bib8","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1056\/NEJMoa031261","article-title":"Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis","volume":"349","author":"Plotz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2010.03.028_bib9","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa070812","article-title":"Treatment of patients with the hypereosinophilic syndrome with mepolizumab","volume":"358","author":"Rothenberg","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2010.03.028_bib10","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","article-title":"Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response","volume":"356","author":"Leckie","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2010.03.028_bib11","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1164\/rccm.200701-085OC","article-title":"A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma","volume":"176","author":"Flood-Page","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2010.03.028_bib12","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.jaci.2010.03.028_bib13","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMoa0805435","article-title":"Mepolizumab for prednisone-dependent asthma with sputum eosinophilia","volume":"360","author":"Nair","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2010.03.028_bib14","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2010.03.028_bib15","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2010.03.028_bib16","first-page":"671","article-title":"Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis","volume":"87","author":"Luqmani","year":"1994","journal-title":"QJM"},{"key":"10.1016\/j.jaci.2010.03.028_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2500\/108854199778681486","article-title":"Eosinophil active cytokines and surface analysis of eosinophils in Churg-Strauss syndrome","volume":"20","author":"Tsukadaira","year":"1999","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2010.03.028_bib18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0002-9440(10)65191-7","article-title":"Involvement of soluble CD95 in Churg-Strauss syndrome","volume":"155","author":"Muschen","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2010.03.028_bib19","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/1529-0131(200008)43:8<1897::AID-ANR29>3.0.CO;2-I","article-title":"Churg-Strauss syndrome: localization of eosinophil major basic protein in damaged tissues","volume":"43","author":"Peen","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2010.03.028_bib20","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0022-3565(24)35210-3","article-title":"Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonal antibody directed to human interleukin-5, in monkeys","volume":"291","author":"Zia-Amirhosseini","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaci.2010.03.028_bib21","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood.V79.12.3101.bloodjournal79123101","article-title":"Interleukin-5, eosinophils, and disease","volume":"79","author":"Sanderson","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2010.03.028_bib22","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1067\/mai.2003.1382","article-title":"Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics","volume":"111","author":"Menzies-Gow","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.03.028_bib23","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1084\/jem.172.5.1425","article-title":"Eosinophilia in transgenic mice expressing interleukin 5","volume":"172","author":"Dent","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2010.03.028_bib24","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1172\/JCI2686","article-title":"Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia","volume":"102","author":"Wang","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2010.03.028_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF03256653","article-title":"Anti-interleukin-5 monoclonal antibodies: preclinical and clinical evidence in asthma models","volume":"2","author":"Leckie","year":"2003","journal-title":"Am J Respir Med"},{"key":"10.1016\/j.jaci.2010.03.028_bib26","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1164\/rccm.200206-525OC","article-title":"Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study","volume":"167","author":"Kips","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2010.03.028_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1164\/rccm.200208-789OC","article-title":"Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway","volume":"167","author":"Flood-Page","year":"2003","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674910005749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674910005749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:20:25Z","timestamp":1758788425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674910005749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0091674910005749"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2010.03.028","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2010.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}